These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 5702859)

  • 1. [Effect of insulin administered directly into the human portal vein].
    Bielewicz J
    Pol Tyg Lek; 1968 Oct; 23(42):1610-1. PubMed ID: 5702859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the action of insulin according to its administration by the portal route or the humeral vein].
    Gilsanz V; Merino C; Barrio E; Sánchez Creus P
    Rev Clin Esp; 1968 Aug; 110(3):203-10. PubMed ID: 5747552
    [No Abstract]   [Full Text] [Related]  

  • 3. Bolus administration of obestatin does not change glucose and insulin levels neither in the systemic nor in the portal circulation of the rat.
    Kiewiet RM; Gauna C; van Aken MO; van de Zande B; van der Lely AJ
    Peptides; 2008 Dec; 29(12):2144-9. PubMed ID: 18930090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different hypoglycemic action of insulin infused into the jugular vein and portal vein of rats].
    Chieri RA; Dujovne IL; Foglia VG
    Rev Soc Argent Biol; 1966; 42(5):199-207. PubMed ID: 5987605
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of insulin secretion: effects of the infusion of glucose, ribose, and other sugars into the portal veins of dogs.
    Goetz FC; Maney JW; Greenberg BZ
    J Lab Clin Med; 1967 Apr; 69(4):537-57. PubMed ID: 6020695
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood insulin in normal newborn infants during provoked hyperglycemia by the intravenous route].
    Levy JM; Segura N; Klein F; Grunewald C; Thierry R; Peter MO
    Arch Fr Pediatr; 1971 Feb; 28(2):133-46. PubMed ID: 5574020
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recanalized umbilical vein conduit for meso-Rex bypass in extrahepatic portal vein obstruction.
    Facciuto ME; Rodriguez-Davalos MI; Singh MK; Rocca JP; Rochon C; Chen W; Katta US; Sheiner PA
    Surgery; 2009 Apr; 145(4):406-10. PubMed ID: 19303989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial of infusion of some therapeutic solutions into the portal vein in man].
    Remigolski S
    Pol Przegl Chir; 1968 Sep; 40(8):847-50. PubMed ID: 5699566
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin kinetics after portal and peripheral injection of labelled insulin. Procedure to be used when no independent measure of liver plasma flow is available.
    Lassen NA; Peri W
    J Nucl Biol Med; 1976; 20(4):180-2. PubMed ID: 1025305
    [No Abstract]   [Full Text] [Related]  

  • 12. PERIPHERAL, HEPATIC, AND NONHEPATIC SPLANCHNIC EFFECTS OF INSULIN IN SHEEP.
    BOWEN JM
    Cornell Vet; 1964 Jan; 54():57-65. PubMed ID: 14116554
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation.
    Osama Gaber A; Chamsuddin A; Fraga D; Fisher J; Lo A
    Transplantation; 2004 Jan; 77(2):309-11. PubMed ID: 14742999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitivity after pancreaticoduodenal transplantation with systemic and portal venous drainage in inbred rats.
    Gu Y; Li J; Li N
    Chin Med J (Engl); 2002 Apr; 115(4):549-51. PubMed ID: 12133295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of glipizide on hepatic and peripheral insulin exchange after glucose administration.
    Nygren A; Sundblad L; Wiechel KL
    Acta Endocrinol Suppl (Copenh); 1980; 239():15-8. PubMed ID: 7001839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transumbilical intraportal drug therapy].
    Sarukhanian OV; Minasian MM; Akopova VA; Oganesian NM; Pogosian PL
    Zh Eksp Klin Med; 1970; 10(1):65-9. PubMed ID: 5457183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous insulin treatment of chronic insulin resistance].
    Lohmann D; Janusch H; Bemm H; Rotzsch W; Kluge HO
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):337-44. PubMed ID: 5731588
    [No Abstract]   [Full Text] [Related]  

  • 19. The umbilical vein antomical and clinical studies of patency.
    Bradley RL; Hoffman RV; Carmody S
    Exp Med Surg; 1971; 29(1):11-4. PubMed ID: 5147593
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic guanylyl cyclase inhibition induces HISS-dependent insulin resistance.
    Correia NC; Guarino MP; Raposo J; Macedo MP
    Proc West Pharmacol Soc; 2002; 45():57-8. PubMed ID: 12434528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.